| abstract |
A broadly effective vaccine composition for cervical cancer is provided. A mixture of HPV16 VLP, HPV 18 VLP, HPV 31 VLP, and HPV 45 VLP, wherein each VLP contains an L1 protein or a functional L1 protein derivative derived from only one HPV genotype. A vaccine composition comprising. It also contains antigens derived from organisms that cause sexually transmitted diseases, such as HSV antigens, chlamydia antigens, HIV antigens or immunologically active fragments thereof, and contains aluminum hydroxide as an adjuvant. [Selection figure] None |